PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Segmentation by product • Comparison by product • Consumables • Instruments • Services • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Americas – Market size and forecast 2017-2022 • APAC – Market size and forecast 2017-2022 • EMEA – Market size and forecast 2017-2022 • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increased adoption of precision medicine • Outsourcing drug discovery process • Growing focus on promotional activities PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abcam • Merck • Promega Corporation • QIAGEN • Thermo Fisher Scientific PART 15: APPENDIX • List of abbreviations Exhibit 01: Parent market Exhibit 02: Global oxidative stress assay market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2017 Exhibit 07: Validation techniques employed for market sizing 2017 Exhibit 08: Global – Market size and forecast 2017-2022 ($ mn) Exhibit 09: Global – Year over year growth 2018-2022 (%) Exhibit 10: Five forces analysis 2017 Exhibit 11: Five forces analysis 2022 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces Exhibit 18: Product – Market share 2017-2022 (%) Exhibit 19: Comparison by product Exhibit 20: Consumables – Market size and forecast 2017-2022 ($ mn) Exhibit 21: Consumables – Year-over-year growth 2018-2022 (%) Exhibit 22: Instruments – Market size and forecast 2017-2022 ($ mn) Exhibit 23: Instruments – Year-over-year growth 2018-2022 (%) Exhibit 24: Services – Market size and forecast 2017-2022 ($ mn) Exhibit 25: Services – Year-over-year growth 2018-2022 (%) Exhibit 26: Market opportunity by product Exhibit 27: Customer landscape Exhibit 28: Global – Market share by geography 2017-2022 (%) Exhibit 29: Regional comparison Exhibit 30: Americas – Market size and forecast 2017-2022 ($ mn) Exhibit 31: Americas – Year-over-year growth 2018-2022 (%) Exhibit 32: Top 3 countries in Americas Exhibit 33: APAC – Market size and forecast 2017-2022 ($ mn) Exhibit 34: APAC – Year-over-year growth 2018-2022 (%) Exhibit 35: Top 3 countries in APAC Exhibit 36: EMEA – Market size and forecast 2017-2022 ($ mn) Exhibit 37: EMEA – Year over year growth 2018-2022 (%) Exhibit 38: Top 3 countries in EMEA Exhibit 39: Market opportunity Exhibit 40: Vendor landscape Exhibit 41: Landscape disruption Exhibit 42: Vendors covered Exhibit 43: Vendor classification Exhibit 44: Market positioning of vendors Exhibit 45: Vendor overview Exhibit 46: Abcam – Business segments Exhibit 47: Abcam – Organizational developments Exhibit 48: Abcam – Geographic focus Exhibit 49: Abcam– Segment focus Exhibit 50: Abcam– Key offerings Exhibit 51: Vendor overview Exhibit 52: Merck – Business segments Exhibit 53: Merck – Organizational developments Exhibit 54: Merck – Geographic focus Exhibit 55: Merck– Segment focus Exhibit 56: Merck – Key offerings Exhibit 57: Vendor overview Exhibit 58: Promega Corporation – Business segments Exhibit 59: Promega Corporation – Organizational developments Exhibit 60: Promega Corporation – Geographic focus Exhibit 61: Promega Corporation – Segment focus Exhibit 62: Promega Corporation – Key offerings Exhibit 63: Vendor overview Exhibit 64: QIAGEN – Business segments Exhibit 65: QIAGEN – Organizational developments Exhibit 66: QIAGEN – Geographic focus Exhibit 67: QIAGEN – Segment focus Exhibit 68: QIAGEN – Key offerings Exhibit 69: Vendor overview Exhibit 70: Thermo Fisher Scientific – Business segments Exhibit 71: Thermo Fisher Scientific– Organizational developments Exhibit 72: Thermo Fisher Scientific – Geographic focus Exhibit 73: Thermo Fisher Scientific– Segment focus Exhibit 74: Thermo Fisher Scientific– Key offerings

Abcam Merck Promega Corporation QIAGEN Thermo Fisher Scientific